Answers are grounded in this paper and cite their sources.
Objective: This study aimed to determine the prevalence of colistin resistance mediated by mcr-1 in Pseudomonas ( P. ) aeruginosa isolates from clinical samples. Methods: P. aeruginosa isolates were collected from various clinical specimens and tested for colistin resistance using the broth microdilution method. Isolates exhibiting resistance underwent polymerase chain reaction (PCR) screening for mcr-1. Antimicrobial susceptibility testing was performed for multiple antibiotics. Results: Sixty five clinical isolates were obtained; 10 (15.4%) were phenotypically resistant to colistin, with minimum inhibitory concentrations (MIC) values ranging from 4-16 μg/mL. The mcr-1 gene was detected in 4 (40.0%) colistin-resistant isolates, constituting 6.2% of all P. aeruginosa isolates. The highest resistance was observed for ceftazidime (70%), amikacin (60%), and ciprofloxacin (60%). Piperacillin-tazobactam was the most effective antibiotic, with 80% susceptibility. Conclusions: The presence of mcr-1 in P. aeruginosa isolates highlights the growing risk of colistin resistance beyond Enterobacteriaceae. Routine surveillance, antimicrobial stewardship, and molecular detection strategies are essential to curb further resistance spread.
No takes yet. Share an insight, caveat, or question.
Gautam et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: